At the 2017 Radiological Society of North America (RSNA) Annual Meeting, GE Healthcare and NVIDIA announced a series of imaging equipment advances powered by NVIDIA’s artificial intelligence (AI) computing platform. The announcements included the new Revolution Frontier computed tomography (CT) system, advancements to the Vivid E95 4-D Ultrasound and development of GE Healthcare’s Applied Intelligence analytics platform.

Siemens Healthineers introduced four new computed tomography (CT) scanners across two platforms at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. The two new scanners in the Somatom go. Platform — Somatom go.All and Somatom go.Top — expand the mobile workflow into advanced fields such as cardiology and CT-guided intervention. With its new high-end systems for single- and dual-source imaging — Somatom Edge Plus and Somatom Force — Siemens Healthineers is introducing the new FAST (Fully Assisting Scanner Technologies) Integrated Workflow with the new FAST 3-D Camera.

Philips announced the debut of IntelliSpace Portal 10, the latest edition of its comprehensive, advanced visualization and quantification platform, at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. This next generation features enhancements across the solution, with a particular focus on oncology to provide radiologists with an improved full set of applications and workflows to support the reading and follow-up of complex oncology cases. IntelliSpace Portal 10 also includes a new 3-D modeling application and has been expanded with the DynaCAD Prostate and Breast solutions through integration with InVivo.

GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of radiofrequency (RF) coils that enables total freedom in coil positioning and handling during a magnetic resonance imaging (MRI) scan. The new coil design is 60 percent lighter than conventional coils, benefiting both patients and technologists, offers greater flexibility in all axes to help conform to patients’ anatomies and fits all patient ages, sizes and shapes.

Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance Analysis methodology, developed at Sheba Medical Center in Tel-Hashomer, Israel, with technology provided by Brainlab. The software analyzes magnetic resonance (MR) images to differentiate regions of efficient contrast clearance from regions with contrast accumulation in most cranial tumor patients to provide additional insight into post-treatment tumor characteristics.